{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:55:17Z","timestamp":1769518517537,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study highlights the clinical features and treatment response of polypoidal choroidal vasculopathy (PCV) among three different branching vascular network (BVN) morphologies in optical coherence tomography angiography (OCTA), and further correlates the BVN features with those under fluorescent angiography (FA) and indocyanine green angiography (ICGA). In total, we reviewed 70 eyes with PCV followed up for\u2009&gt;\u200912\u00a0months. OCTA, ICGA and FA images were obtained at baseline and post-treatments. BVN was assessed using OCTA and divided into three types by a previously described BVN classification: type 1 (trunk), type 2 (glomeruli), and type 3 (stick). At baseline, type 1 BVN had the poorest vision and thinnest subfoveal choroidal thickness (SFCT), whereas type 3 had the best vision and thickest SFCT. The aforementioned trend sustained after treatments. Each BVN morphology in OCTA showed typical features in FA\u2009+\u2009ICGA and encompassed significant correlation (<jats:italic>p<\/jats:italic>\u2009=\u20090.004). In conclusion, OCTA is an innovative imaging tool for the detection and classification of BVN in PCV. Furthermore, OCTA has advantages of being noninvasive and free of systemic toxicities. The BVN can be divided into three types based on morphological characteristics in OCTA, which play crucial roles in clinical presentations and treatment outcomes.<\/jats:p>","DOI":"10.1038\/s41598-021-97340-1","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T10:02:24Z","timestamp":1631095344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical features and prognosis of polypoidal choroidal vasculopathy with different morphologies of branching vascular network on optical coherence tomography angiography"],"prefix":"10.1038","volume":"11","author":[{"given":"Shang-Te","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu-Hsuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Chia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tso-Ting","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ting","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzyy-Chang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-May","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Guo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"key":"97340_CR1","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1001\/archopht.117.11.1503","volume":"117","author":"LA Yannuzzi","year":"1999","unstructured":"Yannuzzi, L. A. et al. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch. Ophthalmol. 117, 1503\u20131510 (1999).","journal-title":"Arch. Ophthalmol."},{"key":"97340_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","volume":"10","author":"LA Yannuzzi","year":"1990","unstructured":"Yannuzzi, L. A., Sorenson, J., Spaide, R. F. & Lipson, B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 10, 1\u20138 (1990).","journal-title":"Retina"},{"key":"97340_CR3","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/archopht.1997.01100150480005","volume":"115","author":"LA Yannuzzi","year":"1997","unstructured":"Yannuzzi, L. A. et al. The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch. Ophthalmol. 115, 478\u2013485 (1997).","journal-title":"Arch. Ophthalmol."},{"issue":"Suppl 1","key":"97340_CR4","first-page":"1","volume":"32","author":"LA Yannuzzi","year":"2012","unstructured":"Yannuzzi, L. A., Sorenson, J., Spaide, R. F. & Lipson, B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 32(Suppl 1), 1\u20138 (2012).","journal-title":"Retina"},{"key":"97340_CR5","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/archopht.121.10.1392","volume":"121","author":"K Sho","year":"2003","unstructured":"Sho, K. et al. Polypoidal choroidal vasculopathy: Incidence, demographic features, and clinical characteristics. Arch. Ophthalmol. 121, 1392\u20131396. https:\/\/doi.org\/10.1001\/archopht.121.10.1392 (2003).","journal-title":"Arch. Ophthalmol."},{"key":"97340_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.survophthal.2003.10.007","volume":"49","author":"AP Ciardella","year":"2004","unstructured":"Ciardella, A. P., Donsoff, I. M., Huang, S. J., Costa, D. L. & Yannuzzi, L. A. Polypoidal choroidal vasculopathy. Surv. Ophthalmol. 49, 25\u201337 (2004).","journal-title":"Surv. Ophthalmol."},{"key":"97340_CR7","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s004170000180","volume":"238","author":"BA Lafaut","year":"2000","unstructured":"Lafaut, B. A., Leys, A. M., Snyers, B., Rasquin, F. & De Laey, J. J. Polypoidal choroidal vasculopathy in Caucasians. Graefes Arch. Clin. Exp. Ophthalmol. 238, 752\u2013759 (2000).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"97340_CR8","first-page":"821","volume":"23","author":"T Desmettre","year":"2000","unstructured":"Desmettre, T., Devoisselle, J. M. & Mordon, S. Fluorescence properties and metabolic features of fluorescein. J. Fr. Ophtalmol. 23, 821\u2013833 (2000).","journal-title":"J. Fr. Ophtalmol."},{"key":"97340_CR9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0002-9394(02)01404-6","volume":"133","author":"M Uyama","year":"2002","unstructured":"Uyama, M. et al. Polypoidal choroidal vasculopathy: Natural history. Am. J. Ophthalmol. 133, 639\u2013648 (2002).","journal-title":"Am. J. Ophthalmol."},{"key":"97340_CR10","doi-asserted-by":"publisher","unstructured":"Lee, W. K., Kim, K. S., Kim, W., Lee, S. B. & Jeon, S. Responses to photodynamic therapy in patients with polypoidal choroidal vasculopathy consisting of polyps resembling grape clusters. Am. J. Ophthalmol. 154, 355\u2013365 e351, https:\/\/doi.org\/10.1016\/j.ajo.2012.02.019 (2012).","DOI":"10.1016\/j.ajo.2012.02.019"},{"key":"97340_CR11","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1136\/bjophthalmol-2014-305606","volume":"99","author":"T Hikichi","year":"2015","unstructured":"Hikichi, T., Kitamei, H. & Shioya, S. Prognostic factors of 2-year outcomes of ranibizumab therapy for polypoidal choroidal vasculopathy. Br. J. Ophthalmol. 99, 817\u2013822. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-305606 (2015).","journal-title":"Br. J. Ophthalmol."},{"key":"97340_CR12","doi-asserted-by":"publisher","unstructured":"Tsujikawa, A. et al. Association of lesion size and visual prognosis to polypoidal choroidal vasculopathy. Am. J. Ophthalmol. 151, 961\u2013972 e961, https:\/\/doi.org\/10.1016\/j.ajo.2011.01.002 (2011).","DOI":"10.1016\/j.ajo.2011.01.002"},{"key":"97340_CR13","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/j.1755-3768.2009.01517.x","volume":"88","author":"SH Byeon","year":"2010","unstructured":"Byeon, S. H., Lew, Y. J., Lee, S. C. & Kwon, O. W. Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy. Acta Ophthalmol. 88, 660\u2013668. https:\/\/doi.org\/10.1111\/j.1755-3768.2009.01517.x (2010).","journal-title":"Acta Ophthalmol."},{"key":"97340_CR14","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1111\/aos.12110","volume":"91","author":"A Kawamura","year":"2013","unstructured":"Kawamura, A., Yuzawa, M., Mori, R., Haruyama, M. & Tanaka, K. Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types. Acta Ophthalmol. 91, e474-481. https:\/\/doi.org\/10.1111\/aos.12110 (2013).","journal-title":"Acta Ophthalmol."},{"key":"97340_CR15","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1097\/IAE.0000000000000777","volume":"35","author":"M Inoue","year":"2015","unstructured":"Inoue, M., Balaratnasingam, C. & Freund, K. B. Optical coherence tomography angiography of polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization. Retina 35, 2265\u20132274. https:\/\/doi.org\/10.1097\/IAE.0000000000000777 (2015).","journal-title":"Retina"},{"key":"97340_CR16","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1167\/iovs.14-16236","volume":"56","author":"G Coscas","year":"2015","unstructured":"Coscas, G. et al. Toward a specific classification of polypoidal choroidal vasculopathy: Idiopathic disease or subtype of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 56, 3187\u20133195. https:\/\/doi.org\/10.1167\/iovs.14-16236 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"97340_CR17","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1136\/bjophthalmol-2014-305059","volume":"98","author":"CS Tan","year":"2014","unstructured":"Tan, C. S., Ngo, W. K., Lim, L. W. & Lim, T. H. A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes. Br. J. Ophthalmol. 98, 1528\u20131533. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-305059 (2014).","journal-title":"Br. J. Ophthalmol."},{"key":"97340_CR18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/archopht.1984.01040030651010","volume":"102","author":"DF Marcus","year":"1984","unstructured":"Marcus, D. F., Bovino, J. A. & Williams, D. Adverse reactions during intravenous fluorescein angiography. Arch. Ophthalmol. 102, 825 (1984).","journal-title":"Arch. Ophthalmol."},{"key":"97340_CR19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0161-6420(86)33697-2","volume":"93","author":"LA Yannuzzi","year":"1986","unstructured":"Yannuzzi, L. A. et al. Fluorescein angiography complication survey. Ophthalmology 93, 611\u2013617 (1986).","journal-title":"Ophthalmology"},{"key":"97340_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/archopht.1996.01100130093018","volume":"114","author":"TW Olsen","year":"1996","unstructured":"Olsen, T. W., Lim, J. I., Capone, A. Jr., Myles, R. A. & Gilman, J. P. Anaphylactic shock following indocyanine green angiography. Arch. Ophthalmol. 114, 97 (1996).","journal-title":"Arch. Ophthalmol."},{"key":"97340_CR21","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1097\/IAE.0b013e31825c1c31","volume":"32","author":"C Ueno","year":"2012","unstructured":"Ueno, C., Gomi, F., Sawa, M. & Nishida, K. Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy. Retina 32, 2006\u20132013. https:\/\/doi.org\/10.1097\/IAE.0b013e31825c1c31 (2012).","journal-title":"Retina"},{"key":"97340_CR22","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ajo.2014.12.012","volume":"159","author":"T Alasil","year":"2015","unstructured":"Alasil, T. et al. En face imaging of the choroid in polypoidal choroidal vasculopathy using swept-source optical coherence tomography. Am. J. Ophthalmol. 159, 634\u2013643. https:\/\/doi.org\/10.1016\/j.ajo.2014.12.012 (2015).","journal-title":"Am. J. Ophthalmol."},{"key":"97340_CR23","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3390\/jcm4050782","volume":"4","author":"CW Wong","year":"2015","unstructured":"Wong, C. W., Wong, T. Y. & Cheung, C. M. Polypoidal choroidal vasculopathy in Asians. J. Clin. Med. 4, 782\u2013821. https:\/\/doi.org\/10.3390\/jcm4050782 (2015).","journal-title":"J. Clin. Med."},{"key":"97340_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/eye.2016.232","volume":"31","author":"K Takayama","year":"2017","unstructured":"Takayama, K. et al. Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy. Eye (Lond.) 31, 45\u201352. https:\/\/doi.org\/10.1038\/eye.2016.232 (2017).","journal-title":"Eye (Lond.)"},{"key":"97340_CR25","doi-asserted-by":"publisher","unstructured":"Tomiyasu, T., Nozaki, M., Yoshida, M. & Ogura, Y. Characteristics of polypoidal choroidal vasculopathy evaluated by optical coherence tomography angiography. Invest. Ophthalmol. Vis. Sci. 57, OCT324-330. https:\/\/doi.org\/10.1167\/iovs.15-18898 (2016).","DOI":"10.1167\/iovs.15-18898"},{"key":"97340_CR26","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00417-015-3228-3","volume":"254","author":"JY Kim","year":"2016","unstructured":"Kim, J. Y., Kwon, O. W., Oh, H. S., Kim, S. H. & You, Y. S. Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy. Graefes Arch. Clin. Exp. Ophthalmol. 254, 1505\u20131510. https:\/\/doi.org\/10.1007\/s00417-015-3228-3 (2016).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"97340_CR27","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41598-018-37384-y","volume":"9","author":"CH Huang","year":"2019","unstructured":"Huang, C. H. et al. Characterizing branching vascular network morphology in polypoidal choroidal vasculopathy by optical coherence tomography angiography. Sci. Rep. 9, 595. https:\/\/doi.org\/10.1038\/s41598-018-37384-y (2019).","journal-title":"Sci. Rep."},{"key":"97340_CR28","doi-asserted-by":"publisher","unstructured":"Lee, Y. A. et al. Photodynamic therapy with or without intravitreal bevacizumab for polypoidal choroidal vasculopathy: two years of follow-up. Am. J. Ophthalmol. 154, 872\u2013880 e872. https:\/\/doi.org\/10.1016\/j.ajo.2012.03.051 (2012).","DOI":"10.1016\/j.ajo.2012.03.051"},{"key":"97340_CR29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jfma.2019.04.012","volume":"119","author":"LJ Chen","year":"2020","unstructured":"Chen, L. J. et al. Management of polypoidal choroidal vasculopathy: Experts consensus in Taiwan. J Formos Med Assoc 119, 569\u2013576. https:\/\/doi.org\/10.1016\/j.jfma.2019.04.012 (2020).","journal-title":"J Formos Med Assoc"},{"key":"97340_CR30","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/IAE.0b013e3182852446","volume":"33","author":"AH Koh","year":"2013","unstructured":"Koh, A. H. et al. Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment. Retina 33, 686\u2013716. https:\/\/doi.org\/10.1097\/IAE.0b013e3182852446 (2013).","journal-title":"Retina"},{"key":"97340_CR31","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1097\/IAE.0000000000001702","volume":"38","author":"SY Chan","year":"2018","unstructured":"Chan, S. Y. et al. Polypoidal choroidal vasculopathy upon optical coherence tomographic angiography. Retina 38, 1187\u20131194. https:\/\/doi.org\/10.1097\/IAE.0000000000001702 (2018).","journal-title":"Retina"},{"key":"97340_CR32","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/jamaophthalmol.2019.0449","volume":"137","author":"Q Bo","year":"2019","unstructured":"Bo, Q. et al. Appearance of polypoidal lesions in patients with polypoidal choroidal vasculopathy using swept-source optical coherence tomographic angiography. JAMA Ophthalmol. 137, 642\u2013650. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.0449 (2019).","journal-title":"JAMA Ophthalmol."},{"key":"97340_CR33","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/jamaophthalmol.2019.0565","volume":"137","author":"V Chaikitmongkol","year":"2019","unstructured":"Chaikitmongkol, V. et al. Sensitivity and specificity of potential diagnostic features detected using fundus photography, optical coherence tomography, and fluorescein angiography for polypoidal choroidal vasculopathy. JAMA Ophthalmol. 137, 661\u2013667. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.0565 (2019).","journal-title":"JAMA Ophthalmol."},{"key":"97340_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.08.006","author":"CM Gemmy Cheung","year":"2020","unstructured":"Gemmy Cheung, C. M. et al. Polypoidal Choroidal vasculopathy: Consensus nomenclature and non-ICGA Diagnostic criteria from the Asia-Pacific Ocular Imaging Society (APOIS) PCV workgroup. Ophthalmology https:\/\/doi.org\/10.1016\/j.ophtha.2020.08.006 (2020).","journal-title":"Ophthalmology"},{"key":"97340_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ophtha.2018.08.035","volume":"126","author":"GJ Jaffe","year":"2019","unstructured":"Jaffe, G. J. et al. Macular morphology and visual acuity in year five of the comparison of age-related macular degeneration treatments trials. Ophthalmology 126, 252\u2013260. https:\/\/doi.org\/10.1016\/j.ophtha.2018.08.035 (2019).","journal-title":"Ophthalmology"},{"key":"97340_CR36","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41598-018-36704-6","volume":"9","author":"TT Lai","year":"2019","unstructured":"Lai, T. T., Hsieh, Y. T., Yang, C. M., Ho, T. C. & Yang, C. H. Biomarkers of optical coherence tomography in evaluating the treatment outcomes of neovascular age-related macular degeneration: a real-world study. Sci. Rep. 9, 529. https:\/\/doi.org\/10.1038\/s41598-018-36704-6 (2019).","journal-title":"Sci. Rep."},{"key":"97340_CR37","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1167\/iovs.16-20967","volume":"58","author":"M Hata","year":"2017","unstructured":"Hata, M. et al. Intraocular Vascular endothelial growth factor levels in pachychoroid neovasculopathy and neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 58, 292\u2013298. https:\/\/doi.org\/10.1167\/iovs.16-20967 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"97340_CR38","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/ceo.13464","volume":"47","author":"CS Tan","year":"2019","unstructured":"Tan, C. S., Ngo, W. K., Lim, L. W., Tan, N. W. & Lim, T. H. EVEREST study report 4: Fluorescein angiography features predictive of polypoidal choroidal vasculopathy. Clin. Exp. Ophthalmol. 47, 614\u2013620. https:\/\/doi.org\/10.1111\/ceo.13464 (2019).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"97340_CR39","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1167\/iovs.17-22683","volume":"59","author":"CS Tan","year":"2018","unstructured":"Tan, C. S., Lim, L. W., Ngo, W. K., Lim, T. H. & Group, E. S. EVEREST Report 5: Clinical outcomes and treatment response of polypoidal choroidal vasculopathy subtypes in a multicenter, randomized controlled trial. Invest. Ophthalmol. Vis. Sci. 59, 889\u2013896. https:\/\/doi.org\/10.1167\/iovs.17-22683 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97340-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97340-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97340-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T15:32:33Z","timestamp":1670081553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97340-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["97340"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-97340-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]},"assertion":[{"value":"27 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17848"}}